Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Upper Eyelid Retraction Related to Thyroid-associated Ophthalmopathy Using Subconjunctival Triamcinolone Injections

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* TAO symptom duration less than 6 months~* Eyelid retraction or swelling~* Participants who is able to sign a consent agreement and proceed study~Exclusion Criteria:~* Previous steroid or radiation treatment for TAO~* Compressive optic neuropathy~* Suspicious of glaucoma or high risk of intraocular pressure elevation~* Patients with eyeball pain and/ or 4 or more of Mourtis' clinical activity score(CAS)~* Patients who are not in euthyroid status at the start of study period and or the whole duration of study period~* Pregnant or breast feeding women

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Triam inj (Type: EXPERIMENTAL): None
- observation group (Type: NO_INTERVENTION): None

Based on this trial design, predict the completion outcome and termination type (if applicable).